Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial)

BACKGROUND: Left ventricular thrombus (LVT), a common complication of acute ST-segment elevation myocardial infarction (STEMI), is associated with increased risk of systemic embolism and high mortality. Current STEMI guidelines recommend adding anticoagulant therapy to dual antiplatelet therapy (DAP...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jie, Ge, Heng, Dong, Jian-Xun, Zhang, Wei, Kong, Ling-Cong, Qiao, Zhi-Qing, Zheng, Ying, Ding, Song, Wan, Fang, Shen, Long, Wang, Wei, Gu, Zhi-Chun, Yang, Fan, Li, Zheng, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186620/
https://www.ncbi.nlm.nih.gov/pubmed/32355836
http://dx.doi.org/10.21037/atm.2020.02.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186620/
https://www.ncbi.nlm.nih.gov/pubmed/32355836
http://dx.doi.org/10.21037/atm.2020.02.117

Ejemplares similares